Comprehensive mutation analysis in NRG Oncology/RTOG 9813: A phase III trial of RT plus TMZ vs RT plus nu for anaplastic astrocytoma and mixed anaplastic oligoastrocytoma (Astrocytoma Dominant). Conference

cited authors

  • Bell, Erica Hlavin; McElroy, Joseph P; Fleming, Jessica; Timmers, Cynthia Dawn; Chakraborty, Arup R; Salavaggione, Andrea L; Chang, Susan Marina; Aldape, Kenneth D; Brachman, David; Shih, Helen Alice; Zhang, Peixin; Mehta, Minesh P; Chakravarti, Arnab

fiu authors

publication date

  • May 20, 2016

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Chicago, IL

Digital Object Identifier (DOI)

Conference

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

volume

  • 34

issue

  • 15